Brian Harvey, VP, U.S. Regulatory Policy at Sanofi, speaks on panel at Partnering for Cures Nov. 8, 2011

Highlights benefits of public-private partnerships like C-Path’s Coalition Against Major Diseases (CAMD):

Stresses importance of standardization when pooling clinical trial data: